TIMELESS and liver cancer: It was observed that higher expression of Cluster 1 might enhance the chemoresistance of these anticancer reagents, implying that inhibition of Cluster 1, or activation of TIMELESS, may render liver cancer cells more sensitive to chemotherapy.